Axiom Investors LLC DE Makes New $8.28 Million Investment in HealthEquity, Inc. $HQY

Key Points

• Axiom Investors LLC DE acquired 93,654 shares of HealthEquity, Inc. for approximately $8.28 million, increasing their ownership to 0.11% of the company.
• HealthEquity's shares received several positive ratings upgrades, with price targets raised by Barrington Research and Deutsche Bank to $125 and $115 respectively, reflecting strong investor confidence.
• Insider trading activity was significant, with Director Jon Kessler selling 134,183 shares valued at over $15 million, indicating a 34.61% reduction in his position.

Axiom Investors LLC DE purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 93,654 shares of the company's stock, valued at approximately $8,276,000. Axiom Investors LLC DE owned 0.11% of HealthEquity at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc acquired a new stake in HealthEquity in the first quarter worth $28,000. Northwestern Mutual Wealth Management Co. increased its position in HealthEquity by 176.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after buying an additional 418 shares during the period. Larson Financial Group LLC increased its position in HealthEquity by 1,366.0% in the first quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after buying an additional 642 shares during the period. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in HealthEquity in the first quarter worth $65,000. Finally, Whipplewood Advisors LLC increased its position in HealthEquity by 5,060.0% in the first quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after buying an additional 759 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have weighed in on HQY. JMP Securities increased their target price on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. Raymond James Financial reaffirmed a "strong-buy" rating and issued a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Barrington Research raised their price target on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a report on Thursday, June 5th. Bank of America upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, HealthEquity presently has a consensus rating of "Buy" and an average target price of $118.55.

Insiders Place Their Bets

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the sale, the executive vice president directly owned 75,689 shares in the company, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jon Kessler sold 97,767 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the completion of the sale, the director owned 75,000 shares in the company, valued at approximately $8,403,750. This trade represents a 56.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is owned by corporate insiders.

HealthEquity Price Performance

HealthEquity stock traded down $1.35 during midday trading on Wednesday, hitting $87.98. The company's stock had a trading volume of 872,967 shares, compared to its average volume of 1,006,108. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock's 50-day moving average price is $96.29 and its 200-day moving average price is $96.21. HealthEquity, Inc. has a 12 month low of $73.84 and a 12 month high of $116.65. The company has a market capitalization of $7.61 billion, a PE ratio of 64.22, a price-to-earnings-growth ratio of 1.35 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The firm had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. During the same period in the previous year, the business earned $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. Analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.